This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
By Jodi Hill Marketing is an essential component of starting a small business. However, many entrepreneurs find themselves with a great product or service but little funding and no idea where to start. A familiar term associated with low-cost promotion is grassroots marketing, a process that involves targeting a small niche group of people and Read More →
With one survey indicating solid voter support and a willing city council going along, Santa Barbara Mayor Helene Schneider has gotten the votes necessary to place a 1 cent general sales tax hike on the ballot for November. The June 28 vote caps a discussion that began earlier this spring when the idea of a Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Just a year ago, the city of Ventura was celebrating its 150th anniversary with a lot of fanfare and one heck of a party. Now, with one of its iconic cultural institutions in need of help, city officials and Ventura County’s board of supervisors will have to weigh the long-term benefits of putting the Museum Read More →
Westlake Village biotechnology company Sienna Biopharmaceuticals filed for an initial public offering with the Securities and Exchange Commission on June 3, stating expectations to raise up to $74.75 million. Founded in 2010, the company develops clinical-stage topical therapies for inflammatory skin diseases and other conditions. ARCH Venture Partners and Venvest Capital led a $40 million Read More →